MedMira Inc. (MMIRF)

USD 0.02

(-70.43%)

Revenue Summary of MedMira Inc.

  • MedMira Inc.'s latest annual revenue in 2023 was 432.52 Thousand CAD , down -54.57% from previous year.
  • MedMira Inc.'s latest quarterly revenue in 2024 Q2 was 148.69 Thousand CAD , up 26.16% from previous quarter.
  • MedMira Inc. reported a annual revenue of 952.12 Thousand CAD in annual revenue 2022, down -55.6% from previous year.
  • MedMira Inc. reported a annual revenue of 2.14 Million CAD in annual revenue 2021, up 133.33% from previous year.
  • MedMira Inc. reported a quarterly revenue of 148.69 Thousand CAD for 2024 Q2, up 26.16% from previous quarter.
  • MedMira Inc. reported a quarterly revenue of 117.86 Thousand CAD for 2024 Q1, up 234.73% from previous quarter.

Annual Revenue Chart of MedMira Inc. (2023 - 2000)

Historical Annual Revenue of MedMira Inc. (2023 - 2000)

Year Revenue Revenue Growth
2023 432.52 Thousand CAD -54.57%
2022 952.12 Thousand CAD -55.6%
2021 2.14 Million CAD 133.33%
2020 919.07 Thousand CAD 74.25%
2019 527.44 Thousand CAD -10.43%
2018 588.87 Thousand CAD -21.2%
2017 747.34 Thousand CAD -66.89%
2016 2.25 Million CAD -44.31%
2015 4.05 Million CAD 60.29%
2014 2.52 Million CAD 26.32%
2013 2 Million CAD 106.2%
2012 970.63 Thousand CAD 6.68%
2011 909.86 Thousand CAD -15.22%
2010 1.07 Million CAD -5.67%
2009 1.13 Million CAD -25.38%
2008 1.52 Million CAD -10.6%
2007 1.7 Million CAD -18.46%
2006 2.09 Million CAD -21.4%
2005 2.66 Million CAD 9.1%
2004 2.43 Million CAD 107.3%
2003 1.17 Million CAD 926.21%
2002 114.64 Thousand CAD -69.32%
2001 373.68 Thousand CAD 376.46%
2000 78.42 Thousand CAD 0.0%

Peer Revenue Comparison of MedMira Inc.

Name Revenue Revenue Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 97.258%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.986%
Intellipharmaceutics International Inc. 65.72 Thousand USD -558.059%
Evofem Biosciences, Inc. 18.21 Million USD 97.626%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.648%
Propanc Biopharma, Inc. - USD -Infinity%
Marizyme, Inc. 645.81 Thousand USD 33.025%
Genus plc 668.8 Million USD 99.935%
Pharming Group N.V. 245.31 Million USD 99.824%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -336.924%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -5.452%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -463.475%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -994.511%
ONE Bio Corp. 52.29 Million USD 99.173%
RVL Pharmaceuticals plc 49.72 Million USD 99.13%
Mesoblast Limited 5.9 Million USD 92.671%
MultiCell Technologies, Inc. 49.32 USD -876884.996%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.539%
Genscript Biotech Corporation 839.52 Million USD 99.948%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2354.622%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 22.446%
Oncotelic Therapeutics, Inc. 70 Thousand USD -517.899%
Skye Bioscience, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -471.191%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 34.316%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -784.517%
Q BioMed Inc. 284.35 Thousand USD -52.11%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.997%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.702%
Enzolytics Inc. 52.79 Thousand USD -719.246%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 28.922%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.965%
Northwest Biotherapeutics, Inc. 1.93 Million USD 77.612%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -43196.196%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -208.416%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 29.942%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 56.649%
Capstone Therapeutics Corp. 48.35 Million USD 99.105%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 97.408%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -82.841%
Regen BioPharma, Inc. 236.56 Thousand USD -82.841%
Affymax, Inc. 1.36 Million USD 68.405%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 94.447%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 8.697%
SYBLEU INC 11.69 Thousand USD -3598.093%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3227.146%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -994.068%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 87.011%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 93.51%
IntelGenx Technologies Corp. 1.03 Million USD 58.371%
Gelesis Holdings, Inc. 25.76 Million USD 98.321%
CSL Limited 14.8 Billion USD 99.997%
Cellectis S.A. 755 Thousand USD 42.711%